Chapter 3 of the EU GMP Guide asks a simple question of every facility: does the design and operation prevent errors and cross-contamination? Since the 2014 revision, the answer must rest on risk and toxicology.
The revised chapter
Chapter 3 on premises and equipment was revised in 2014 and has applied since 1 March 2015. Its central statement is that cross-contamination should be prevented for all products by appropriate design and operation of manufacturing facilities. The measures should be commensurate with the risk, and quality risk management principles should be used to assess and control it.
When dedicated facilities are required
Chapter 3 states that dedicated premises or equipment may be needed in certain circumstances. These include situations where:
- the risk cannot be adequately controlled by operational and technical measures;
- scientific data from the toxicological evaluation do not support a controllable risk, for example with highly sensitising materials;
- relevant residue limits, derived from the toxicological evaluation, cannot be satisfactorily determined by a validated analytical method.
This links directly to the EMA guideline on health-based exposure limits and to cleaning validation under Annex 15.
Layout and flow
- Premises should be located, designed and maintained to suit the operations, with a layout that minimises the risk of errors.
- Production areas should preferably follow a logical sequence matching the operations and the required cleanliness levels.
- Working and in-process storage space should allow orderly positioning of equipment and materials.
- Weighing of starting materials is usually done in a separate weighing room, and dusty operations such as sampling and weighing need specific measures to prevent cross-contamination.
- Pipework and services should avoid hard-to-clean recesses and, where possible, be accessible from outside manufacturing areas.
Quality control areas
QC laboratories should normally be separated from production areas, and biological, microbiological and radioisotope laboratories should be separated from each other. Adequate space and storage for samples and records are expected.
Equipment
- Equipment should be designed, located and maintained to suit its purpose, and should be easy to clean thoroughly.
- Product contact parts must not be reactive, additive or absorptive to an extent that affects quality.
- Measuring, weighing, recording and control equipment must be calibrated and checked at defined intervals, with records kept.
- Defective equipment should be removed from production and QC areas or at least clearly labelled as defective.
Using the chapter in practice
A documented cross-contamination risk assessment for each shared area, supported by toxicological data, airflow and pressure design, personnel and material flow, and cleaning evidence, is the most direct way to show compliance. Revisit it whenever products, equipment or layouts change.
A short self-check
- Is there a documented cross-contamination risk assessment for each shared area?
- Are toxicological data referenced in that assessment?
- Is the assessment reviewed when a new product is introduced?
How PQRA helps
PQRA helps manufacturers prepare cross-contamination risk assessments, facility gap analyses against Chapter 3 and related annexes, and the documentation needed for inspections or new product introductions into existing facilities. We work with your engineering, production and quality teams to keep the assessment practical.
Contact PQRA to discuss how we can support your quality system.


No responses yet